FDA Warning Letter alerts for your Indian and Chinese suppliers.
Know within 24 hours when an external manufacturer receives a Warning Letter, Form 483, or OAI inspection classification. No more surprises from supplier quality events.
5 suppliers free for 14 days. FDA.gov citations included.
cGMP deficiencies and facility observations requiring sourcing attention.
FDA enforcement action matched to a known supplier facility.
Entity mapping checks multiple facilities under the same commercial name.
How it works
Add suppliers
Type commercial names. RxTrialHub maps aliases and FEI numbers over time.
Monitor FDA actions
We track Warning Letters, OAI classifications, and Form 483 signals.
Act within 24 hours
Alerts include severity, FEI, FDA source links, and review status.
Built around supplier identity mapping
The defensible layer is FEI-to-commercial-name mapping. A buyer can type Aurobindo and the system can check multiple FDA facility identifiers.
Pricing to test
Start narrow, then expand coverage as your supplier list grows.
Get weekly FDA supplier alerts
Useful even before your full watchlist is configured.